Portal hypertension in children--the changing spectrum
Related Experiment Videos
Insights
Trends in childhood portal hypertension (PHT) etiology and management have shifted. Sclerotherapy is increasingly used, while surgery
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Clinical Medicine
- Medical Research
Background:
- Portal hypertension (PHT) in children presents complex etiological and management challenges.
- Understanding evolving trends is crucial for optimizing patient care.
- Historical data provides a baseline for analyzing changes over time.
Purpose of the Study:
- To analyze the changing trends in the causes (etiology) and treatments (management) of childhood portal hypertension.
- To compare PHT cases from two distinct time periods to identify significant shifts.
- To evaluate the impact of new therapeutic and diagnostic modalities on PHT management.
Main Methods:
- Comparative analysis of pediatric PHT admissions over two periods: 1948-1971 and 1971-1991.
- Review of patient records to determine etiology (intrahepatic vs. extrahepatic) and management strategies.
- Assessment of changes in diagnostic approaches, including imaging techniques.
Main Results:
- Significant shifts observed in the etiology of PHT between the two study periods.
- Increased utilization of sclerotherapy, with a corresponding decrease in the role of surgical interventions.
- Advancements in diagnostic imaging and the emergence of organ transplantation as a viable treatment option.
Conclusions:
- Childhood portal hypertension management has evolved, with a trend towards less invasive therapies like sclerotherapy.
- Diagnostic capabilities have improved, aiding in earlier and more accurate PHT identification.
- Organ transplantation offers a new therapeutic avenue for severe pediatric PHT cases.
Abstract:
This report is an analysis of changing trends in the etiology and management of portal hypertension (PHT) in childhood. The study compared the 53 admissions to the Royal Children's Hospital from 1971 to 1991 (33 intrahepatic, 20 extrahepatic) with the 77 admissions (22 intrahepatic, 54 extrahepatic, 1 with a congenital anomaly of the mesenteric vein) from the previous 23-year period (1948 to 1971). In addition to the differences in etiology, there has been (1) an increasing role for sclerotherapy as a therapeutic modality (and with this, lessening of the role of surgery), (2) a different approach to investigation (particularly imaging techniques), and (3) the availability of organ transplantation.